Enveric Biosciences (ENVB) Stock Research

Enveric Biosciences

· ENVB

Dashboard

Financials

Ratios

Valuation

Statistics

6.49 M

+2.41%

Over a week ago

Psychedelic: Definium's LSD-based drug meets endpoints in GAD study

Sep 17, 9:51 AM

Enveric receives Notice of Allowance from USPTO for application for EVM401

ENVB

Sep 15, 8:17 AM

Psychedelic: Enveric, Helus, Bright Minds report earnings results

Aug 20, 11:27 AM

Psychedelic: Compass Pathways, GH Research report quarterly earnings

Aug 6, 10:23 AM

Enveric Biosciences reports new preclinical data on EB-003

ENVB

Aug 5, 8:05 AM

Enveric 'welcomes' final FDA guidance for psychedelic drug development

ENVB

Jul 28, 8:04 AM

Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003

Jun 4, 10:57 AM

Enveric Biosciences initiates IND-enabling Genotoxicity studies of EB-003

ENVB

Jun 2, 8:04 AM

Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings

May 21, 11:26 AM

Enveric Biosciences reports preclinical results from analysis of EB-003

ENVB

May 19, 8:11 AM

What You Missed On Wall Street On Friday

+26

May 15, 4:13 PM

Midday Fly By: Applied Materials, Figma post 'beat and raise' reports

+26

May 15, 11:53 AM

Enveric Biosciences sees cash runway into 1Q27

ENVB

May 15, 8:04 AM

Enveric Biosciences reports Q1 EPS ($1.08) vs. ($14.58) last year

ENVB

May 15, 8:04 AM

Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings

May 14, 11:09 AM

Enveric issued U.S. patent for methods of treating psychiatric disorders

ENVB

May 13, 8:08 AM

Psychedelic: Jefferies initiates Compass Pathways with a Buy rating

May 7, 10:26 AM

Enveric Biosciences highlights preclinical data for EB-003

ENVB

May 5, 8:02 AM

Enveric Biosciences trading resumes

ENVB

Apr 30, 9:38 AM

Enveric Biosciences trading halted, volatility trading pause

ENVB

Apr 30, 9:33 AM

Enveric Biosciences files to sell 6.82M shares of common stock

ENVB

Apr 23, 7:25 PM

Enveric Biosciences prices $13.9M at-the-market offering

ENVB

Apr 16, 8:03 PM

Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial

Apr 2, 9:50 AM

Enveric Biosciences secures new U.S. patent for its EVM301 series

ENVB

Mar 31, 8:12 AM

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

Mar 19, 11:41 AM

Charts

Over a week ago

Psychedelic: Definium's LSD-based drug meets endpoints in GAD study

Sep 17, 9:51 AM

Enveric receives Notice of Allowance from USPTO for application for EVM401

ENVB

Sep 15, 8:17 AM

Psychedelic: Enveric, Helus, Bright Minds report earnings results

Aug 20, 11:27 AM

Psychedelic: Compass Pathways, GH Research report quarterly earnings

Aug 6, 10:23 AM

Enveric Biosciences reports new preclinical data on EB-003

ENVB

Aug 5, 8:05 AM

Enveric 'welcomes' final FDA guidance for psychedelic drug development

ENVB

Jul 28, 8:04 AM

Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003

Jun 4, 10:57 AM

Enveric Biosciences initiates IND-enabling Genotoxicity studies of EB-003

ENVB

Jun 2, 8:04 AM

Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings

May 21, 11:26 AM

Enveric Biosciences reports preclinical results from analysis of EB-003

ENVB

May 19, 8:11 AM

What You Missed On Wall Street On Friday

+26

May 15, 4:13 PM

Midday Fly By: Applied Materials, Figma post 'beat and raise' reports

+26

May 15, 11:53 AM

Enveric Biosciences sees cash runway into 1Q27

ENVB

May 15, 8:04 AM

Enveric Biosciences reports Q1 EPS ($1.08) vs. ($14.58) last year

ENVB

May 15, 8:04 AM

Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings

May 14, 11:09 AM

Enveric issued U.S. patent for methods of treating psychiatric disorders

ENVB

May 13, 8:08 AM

Psychedelic: Jefferies initiates Compass Pathways with a Buy rating

May 7, 10:26 AM

Enveric Biosciences highlights preclinical data for EB-003

ENVB

May 5, 8:02 AM

Enveric Biosciences trading resumes

ENVB

Apr 30, 9:38 AM

Enveric Biosciences trading halted, volatility trading pause

ENVB

Apr 30, 9:33 AM

Enveric Biosciences files to sell 6.82M shares of common stock

ENVB

Apr 23, 7:25 PM

Enveric Biosciences prices $13.9M at-the-market offering

ENVB

Apr 16, 8:03 PM

Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial

Apr 2, 9:50 AM

Enveric Biosciences secures new U.S. patent for its EVM301 series

ENVB

Mar 31, 8:12 AM

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

Mar 19, 11:41 AM

Company News

Charts